VCF Treatments

The global market for minimally invasive vertebral compression fracture (MIVCF) treatments, comprising vertebroplasty and vertebral augmentation procedures, generated over $600 million in revenue in 2009. Increased physician training and awareness combined with favorable reimbursement environments and aging demographics will be the primary factors driving this market. Surgeon concern over the risk of complications and a lack of full reimbursement in some countries will, however, impede growth.